Neurology Minute
by American Academy of Neurology
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇰🇷KR · Mental Health#1061K to 10K
- 🇯🇵JP · Mental Health#1431K to 10K
- 🇹🇭TH · Mental Health#533K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.5K to 9K🎙 Daily cadence·1,000 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇰🇷33%🇯🇵33%🇹🇭33% - Active Followers
Loyal subscribers who consistently listen
1.5K to 9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHosts
Recent guests
Recent episodes
Lab Minute: Human Prion Disease
Jul 21, 2026
3m 39s
July 2026 President Spotlight: Mid-Year Update
Jul 20, 2026
4m 04s
Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants
Jul 17, 2026
2m 42s
When Drug Marketing Masquerades as Clinical Trials
Jul 16, 2026
2m 34s
The DRAIN Trial
Jul 15, 2026
3m 44s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/21/26 | prion diseaseneurology+1 | Dr. Stacey Clardy | — | — | human prion diseaseneurology+3 | — | 3m 39s | ||
| 7/20/26 | brain healthadvocacy+3 | Dr. Natalia Rost | AAN | — | AANbrain health+3 | — | 4m 04s | ||
| 7/17/26 | ALSlongitudinal care+3 | Dr. Derek StittDr. Jennifer Morganroth | American Academy of NeurologyPreparing Amyotrophic Lateral Sclerosis Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants | — | ALSlongitudinal care+5 | — | 2m 42s | ||
| 7/16/26 | drug marketingclinical trials+3 | Dr. Justin AbbatemarcoSukhun Kang | American Academy of NeurologyThe Conversation | — | drug marketingclinical trials+4 | — | 2m 34s | ||
| 7/15/26 | idiopathic normal pressure hydrocephalusDRAIN trial+3 | Dr. Margarita Fedorova | acetazolamideAmerican Academy of Neurology+3 | — | DRAIN trialacetazolamide+3 | — | 3m 44s | ||
| 7/14/26 | headache diagnosisemergency medicine+4 | Dr. Matthew Robbins | American Academy of NeurologyJAMA+1 | — | headachediagnosis+6 | — | 2m 39s | ||
| 7/13/26 | epilepsy carepediatric to adult transition+3 | Dr. Dara AlbertDr. Scott Perry | American Academy of NeurologyAddressing Barriers to Transitioning Pediatric Patients With Epilepsy to Adult Health Care in the United States: A Narrative Review | — | epilepsytransition+5 | — | 2m 21s | ||
| 7/10/26 | neurologymedical journal+3 | Dr. Chris BoesDr. José Merino | NeurologyAmerican Academy of Neurology | — | Neurologymedical journal+3 | — | 2m 12s | ||
| 7/9/26 | epilepsy carepediatric to adult transition+3 | Dr. Dara AlbertDr. Scott Perry | American Academy of NeurologyNeurol Clin Pract+1 | — | epilepsytransition+4 | — | 2m 20s | ||
| 5/5/26 | immunotherapyMOGAD+4 | Dr. Benjamin P. Trewin | rituximabocrelizumab+6 | — | MOGADmaintenance immunotherapy+5 | — | 5m 24s | ||
| 5/4/26 | Epstein-Barr VirusMultiple Sclerosis+3 | Dr. Paulus Rommer | American Academy of NeurologyJAMA Neurol+1 | — | Epstein-Barr VirusMultiple Sclerosis+6 | — | 1m 35s | ||
| 5/1/26 | strokesystemic vasculitis+3 | Dr. Zohaib SiddiqiDr. Laurence Poirier | American Academy of NeurologyNeurology | — | systemic illnessstrokes+3 | — | 2m 10s | ||
| 4/30/26 | Epstein-Barr virusmultiple sclerosis+3 | Dr. Paulus Rommer | JAMA NeurologyAmerican Academy of Neurology+1 | — | Epstein-Barr virusmultiple sclerosis+3 | — | 2m 14s | ||
| 4/29/26 | immunotherapyMOGAD+3 | Dr. Justin AbbatemarcoDr. Benjamin P. Trewin | American Academy of Neurology | — | MOGADimmunotherapy+3 | — | 4m 17s | ||
| 4/28/26 | neuroscience researchfederal funding+3 | — | American Academy of Neurology | — | neurosciencefederal funding+3 | — | 2m 11s | ||
| 4/27/26 | residency applicationneurology+3 | Casey Kozak | American Academy of Neurology | — | neurology residencyapplication process+3 | — | 4m 32s | ||
| 4/24/26 | head CTemergency departments+3 | Dr. Andy SoutherlandDr. Layne Dylla | American Academy of NeurologyTrends in Head CT Use in US Emergency Department Patients From 2007 to 2022: A Nationwide Analysis | — | head CTemergency department+4 | — | 1m 59s | ||
| 4/23/26 | neurologyeducation+4 | Dr. Alison Christy | 2026 Ted Burns Humanism in Neurology Award | — | neurologyhumanism+4 | — | 3m 25s | ||
| 4/22/26 | headache disordersolder adults+3 | Ayesha Sohail | American Academy of NeurologyGlobal Burden of Headache Disorders in Older Adults (Aged ≥ 55 Years) from 1990-2021 | — | headache disordersolder adults+4 | — | 4m 05s |
Showing 19 of 19
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Neurology Minute
Peaked at #53 in TH, currently #53 in TH.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| TH | — | #53 | #53 | — |
| South Korea | — | #106 | #106 | — |
| Japan | — | #143 | #143 | — |
| TH | — | #161 | #161 | — |
Chart Positions
4 placements across 3 markets.
Chart Positions
4 placements across 3 markets.